Skip to content

Clinical trials

Terminated Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Status: Terminated Country / region: China Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20101
20112
20131
20141
20151
20172
20192
20201
20211
20221
20241
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shenzhen Geno-Immune Medical Institute4
AbbVie2
Abbott1
Amgen1
Capital Medical University1
Cellxpert Biotechnology Corp.1
Elpiscience Biopharma, Ltd.1
GlaxoSmithKline1
Hutchison Medipharma Limited1
National Cancer Institute (NCI)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms20
Carcinoma, Hepatocellular3
Carcinoma2
Liver Neoplasms2
Adenocarcinoma1
Anemia1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Ovarian Epithelial1
Colorectal Neoplasms1
Digestive System Diseases1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.